Walgreens Boots Alliance, Inc. (0LSZ.L)
USD 10.22
(-7.23%)
USD 10.22
(-7.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 81.03 Billion USD | -16.14% |
| 2023 | 96.62 Billion USD | 7.22% |
| 2022 | 90.12 Billion USD | 10.87% |
| 2021 | 81.28 Billion USD | -6.76% |
| 2020 | 87.17 Billion USD | 27.75% |
| 2019 | 68.23 Billion USD | 0.17% |
| 2018 | 68.12 Billion USD | 3.2% |
| 2017 | 66 Billion USD | -9.19% |
| 2016 | 72.68 Billion USD | 5.68% |
| 2015 | 68.78 Billion USD | 84.99% |
| 2014 | 37.18 Billion USD | 4.79% |
| 2013 | 35.48 Billion USD | 6.03% |
| 2012 | 33.46 Billion USD | 21.88% |
| 2011 | 27.45 Billion USD | 4.49% |
| 2010 | 26.27 Billion USD | 4.51% |
| 2009 | 25.14 Billion USD | 12.19% |
| 2008 | 22.41 Billion USD | 16.03% |
| 2007 | 19.31 Billion USD | 12.74% |
| 2006 | 17.13 Billion USD | 17.27% |
| 2005 | 14.6 Billion USD | 9.49% |
| 2004 | 13.34 Billion USD | 16.98% |
| 2003 | 11.4 Billion USD | 15.46% |
| 2002 | 9.87 Billion USD | 11.83% |
| 2001 | 8.83 Billion USD | 24.35% |
| 2000 | 7.1 Billion USD | 20.27% |
| 1999 | 5.9 Billion USD | 20.5% |
| 1998 | 4.9 Billion USD | 16.52% |
| 1997 | 4.2 Billion USD | 15.78% |
| 1996 | 3.63 Billion USD | 11.71% |
| 1995 | 3.25 Billion USD | 11.82% |
| 1994 | 2.9 Billion USD | 14.73% |
| 1993 | 2.53 Billion USD | 6.81% |
| 1992 | 2.37 Billion USD | 13.32% |
| 1991 | 2.09 Billion USD | 9.46% |
| 1990 | 1.91 Billion USD | 13.83% |
| 1989 | 1.68 Billion USD | 11.19% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 82.98 Billion USD | -1.45% |
| 2024 Q1 | 97.82 Billion USD | 1.24% |
| 2024 Q4 | 81.03 Billion USD | -2.35% |
| 2024 Q2 | 84.2 Billion USD | -13.92% |
| 2023 Q2 | 100.47 Billion USD | 8.19% |
| 2023 FY | 96.62 Billion USD | 7.22% |
| 2023 Q1 | 92.87 Billion USD | 3.05% |
| 2023 Q3 | 98.6 Billion USD | -1.87% |
| 2023 Q4 | 96.62 Billion USD | -2.0% |
| 2022 FY | 90.12 Billion USD | 10.87% |
| 2022 Q4 | 90.12 Billion USD | -2.84% |
| 2022 Q2 | 92.68 Billion USD | -3.96% |
| 2022 Q1 | 96.5 Billion USD | 18.73% |
| 2022 Q3 | 92.75 Billion USD | 0.08% |
| 2021 Q3 | 91.92 Billion USD | 1.1% |
| 2021 Q4 | 81.28 Billion USD | -11.57% |
| 2021 Q1 | 89.16 Billion USD | 2.29% |
| 2021 Q2 | 90.92 Billion USD | 1.97% |
| 2021 FY | 81.28 Billion USD | -6.76% |
| 2020 FY | 87.17 Billion USD | 27.75% |
| 2020 Q1 | 90.8 Billion USD | 33.07% |
| 2020 Q2 | 90 Billion USD | -0.89% |
| 2020 Q3 | 86.44 Billion USD | -3.95% |
| 2020 Q4 | 87.17 Billion USD | 0.84% |
| 2019 FY | 68.23 Billion USD | 0.17% |
| 2019 Q3 | 68.58 Billion USD | -3.5% |
| 2019 Q4 | 68.23 Billion USD | -0.51% |
| 2019 Q2 | 71.07 Billion USD | 1.62% |
| 2019 Q1 | 69.94 Billion USD | 2.67% |
| 2018 FY | 68.12 Billion USD | 3.2% |
| 2018 Q1 | 66.61 Billion USD | 0.92% |
| 2018 Q2 | 70.81 Billion USD | 6.3% |
| 2018 Q3 | 70.15 Billion USD | -0.94% |
| 2018 Q4 | 68.12 Billion USD | -2.89% |
| 2017 Q1 | 71.91 Billion USD | -1.07% |
| 2017 FY | 66 Billion USD | -9.19% |
| 2017 Q4 | 66 Billion USD | -11.01% |
| 2017 Q3 | 74.17 Billion USD | 2.3% |
| 2017 Q2 | 72.5 Billion USD | 0.82% |
| 2016 Q3 | 67.33 Billion USD | 1.43% |
| 2016 Q2 | 66.38 Billion USD | -3.31% |
| 2016 FY | 72.68 Billion USD | 5.68% |
| 2016 Q4 | 72.68 Billion USD | 7.95% |
| 2016 Q1 | 68.65 Billion USD | -0.18% |
| 2015 Q4 | 68.78 Billion USD | -2.64% |
| 2015 Q2 | 71.35 Billion USD | 46.79% |
| 2015 Q1 | 48.61 Billion USD | 30.74% |
| 2015 FY | 68.78 Billion USD | 84.99% |
| 2015 Q3 | 70.64 Billion USD | -1.0% |
| 2014 Q1 | 36.48 Billion USD | 2.82% |
| 2014 Q4 | 37.18 Billion USD | -0.56% |
| 2014 Q3 | 37.39 Billion USD | 0.84% |
| 2014 Q2 | 37.08 Billion USD | 1.64% |
| 2014 FY | 37.18 Billion USD | 4.79% |
| 2013 FY | 35.48 Billion USD | 6.03% |
| 2013 Q4 | 35.48 Billion USD | -1.0% |
| 2013 Q3 | 35.84 Billion USD | 0.78% |
| 2013 Q2 | 35.56 Billion USD | 0.87% |
| 2013 Q1 | 35.25 Billion USD | 5.37% |
| 2012 Q1 | 27.42 Billion USD | -0.09% |
| 2012 FY | 33.46 Billion USD | 21.88% |
| 2012 Q4 | 33.46 Billion USD | 23.03% |
| 2012 Q3 | 27.19 Billion USD | 2.17% |
| 2012 Q2 | 26.62 Billion USD | -2.94% |
| 2011 Q3 | 27.31 Billion USD | 1.63% |
| 2011 Q4 | 27.45 Billion USD | 0.51% |
| 2011 Q1 | 27.04 Billion USD | 2.93% |
| 2011 Q2 | 26.87 Billion USD | -0.61% |
| 2011 FY | 27.45 Billion USD | 4.49% |
| 2010 Q2 | 26.33 Billion USD | -0.81% |
| 2010 FY | 26.27 Billion USD | 4.51% |
| 2010 Q1 | 26.54 Billion USD | 5.59% |
| 2010 Q4 | 26.27 Billion USD | -1.62% |
| 2010 Q3 | 26.7 Billion USD | 1.42% |
| 2009 Q4 | 25.14 Billion USD | -0.0% |
| 2009 FY | 25.14 Billion USD | 12.19% |
| 2009 Q1 | 24.51 Billion USD | 9.38% |
| 2009 Q2 | 24.82 Billion USD | 1.27% |
| 2009 Q3 | 25.14 Billion USD | 1.28% |
| 2008 Q2 | 20.74 Billion USD | 1.33% |
| 2008 FY | 22.41 Billion USD | 16.03% |
| 2008 Q1 | 20.47 Billion USD | 6.02% |
| 2008 Q3 | 21.58 Billion USD | 4.05% |
| 2008 Q4 | 22.41 Billion USD | 3.81% |
| 2007 Q1 | 18.02 Billion USD | 5.22% |
| 2007 Q2 | 17.66 Billion USD | -1.98% |
| 2007 Q3 | 17.94 Billion USD | 1.56% |
| 2007 Q4 | 19.31 Billion USD | 7.63% |
| 2007 FY | 19.31 Billion USD | 12.74% |
| 2006 Q1 | 15.4 Billion USD | 5.43% |
| 2006 Q3 | 16.44 Billion USD | 5.13% |
| 2006 Q4 | 17.13 Billion USD | 4.19% |
| 2006 FY | 17.13 Billion USD | 17.27% |
| 2006 Q2 | 15.63 Billion USD | 1.54% |
| 2005 Q4 | 14.6 Billion USD | 1.86% |
| 2005 FY | 14.6 Billion USD | 9.49% |
| 2005 Q3 | 14.34 Billion USD | 1.18% |
| 2005 Q2 | 14.17 Billion USD | 0.17% |
| 2005 Q1 | 14.14 Billion USD | 6.05% |
| 2004 Q1 | 12.09 Billion USD | 6.06% |
| 2004 Q2 | 12.29 Billion USD | 1.67% |
| 2004 Q3 | 12.75 Billion USD | 3.7% |
| 2004 FY | 13.34 Billion USD | 16.98% |
| 2004 Q4 | 13.34 Billion USD | 4.61% |
| 2003 Q3 | 10.95 Billion USD | 1.94% |
| 2003 Q2 | 10.75 Billion USD | 3.7% |
| 2003 FY | 11.4 Billion USD | 15.46% |
| 2003 Q1 | 10.36 Billion USD | 4.95% |
| 2003 Q4 | 11.4 Billion USD | 4.07% |
| 2002 FY | 9.87 Billion USD | 11.83% |
| 2002 Q3 | 9.45 Billion USD | 3.01% |
| 2002 Q4 | 9.87 Billion USD | 4.47% |
| 2002 Q1 | 9.69 Billion USD | 9.77% |
| 2002 Q2 | 9.18 Billion USD | -5.33% |
| 2001 Q4 | 8.83 Billion USD | 4.59% |
| 2001 Q3 | 8.44 Billion USD | 3.31% |
| 2001 Q2 | 8.17 Billion USD | 3.35% |
| 2001 FY | 8.83 Billion USD | 24.35% |
| 2001 Q1 | 7.91 Billion USD | 11.37% |
| 2000 Q1 | 6.47 Billion USD | 9.58% |
| 2000 Q2 | 6.41 Billion USD | -0.89% |
| 2000 Q3 | 6.63 Billion USD | 3.37% |
| 2000 FY | 7.1 Billion USD | 20.27% |
| 2000 Q4 | 7.1 Billion USD | 7.14% |
| 1999 Q4 | 5.9 Billion USD | 5.62% |
| 1999 Q1 | 5.24 Billion USD | 6.9% |
| 1999 FY | 5.9 Billion USD | 20.5% |
| 1999 Q2 | 5.41 Billion USD | 3.29% |
| 1999 Q3 | 5.59 Billion USD | 3.32% |
| 1998 FY | 4.9 Billion USD | 16.52% |
| 1998 Q1 | 4.45 Billion USD | 5.85% |
| 1998 Q2 | 4.5 Billion USD | 1.1% |
| 1998 Q3 | 4.58 Billion USD | 1.73% |
| 1998 Q4 | 4.9 Billion USD | 7.03% |
| 1997 Q1 | 3.94 Billion USD | 8.69% |
| 1997 Q2 | 3.91 Billion USD | -0.96% |
| 1997 Q3 | 3.99 Billion USD | 2.11% |
| 1997 Q4 | 4.2 Billion USD | 5.33% |
| 1997 FY | 4.2 Billion USD | 15.78% |
| 1996 Q4 | 3.63 Billion USD | 3.69% |
| 1996 Q2 | 3.53 Billion USD | 0.65% |
| 1996 Q1 | 3.51 Billion USD | 7.96% |
| 1996 FY | 3.63 Billion USD | 11.71% |
| 1996 Q3 | 3.5 Billion USD | -0.85% |
| 1995 Q1 | 3.1 Billion USD | 6.7% |
| 1995 Q3 | 3.15 Billion USD | 4.14% |
| 1995 Q2 | 3.03 Billion USD | -2.3% |
| 1995 Q4 | 3.25 Billion USD | 3.01% |
| 1995 FY | 3.25 Billion USD | 11.82% |
| 1994 Q2 | 2.68 Billion USD | 0.34% |
| 1994 Q4 | 2.9 Billion USD | 4.32% |
| 1994 Q3 | 2.78 Billion USD | 3.95% |
| 1994 FY | 2.9 Billion USD | 14.73% |
| 1994 Q1 | 2.67 Billion USD | 5.44% |
| 1993 Q1 | 2.52 Billion USD | 6.26% |
| 1993 Q4 | 2.53 Billion USD | 2.03% |
| 1993 Q3 | 2.48 Billion USD | 3.67% |
| 1993 FY | 2.53 Billion USD | 6.81% |
| 1993 Q2 | 2.39 Billion USD | -4.97% |
| 1992 FY | 2.37 Billion USD | 13.32% |
| 1992 Q1 | 2.19 Billion USD | 4.99% |
| 1992 Q2 | 2.23 Billion USD | 1.82% |
| 1992 Q3 | 2.28 Billion USD | 2.02% |
| 1992 Q4 | 2.37 Billion USD | 3.9% |
| 1991 Q3 | 2.06 Billion USD | 2.29% |
| 1991 Q1 | 2.02 Billion USD | 5.69% |
| 1991 FY | 2.09 Billion USD | 9.46% |
| 1991 Q2 | 2.01 Billion USD | -0.27% |
| 1991 Q4 | 2.09 Billion USD | 1.53% |
| 1990 Q4 | 1.91 Billion USD | 4.59% |
| 1990 FY | 1.91 Billion USD | 13.83% |
| 1990 Q3 | 1.82 Billion USD | 2.09% |
| 1990 Q2 | 1.79 Billion USD | -1.05% |
| 1990 Q1 | 1.81 Billion USD | 7.74% |
| 1989 FY | 1.68 Billion USD | 11.19% |
| 1989 Q4 | 1.68 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| uniQure N.V. | 831.68 Million USD | -9643.666% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -8547.47% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -10317.674% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -48863.771% |
| bluebird bio, Inc. | 619.16 Million USD | -12988.195% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -64294.806% |
| Imunon, Inc. | 21.91 Million USD | -369626.913% |
| Editas Medicine, Inc. | 499.15 Million USD | -16134.902% |
| IQVIA Holdings Inc. | 26.68 Billion USD | -203.725% |
| Mettler-Toledo International Inc. | 3.35 Billion USD | -2315.01% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -6660.407% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | -2392.373% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -5651.478% |
| Verastem, Inc. | 149.71 Million USD | -54026.424% |
| Waters Corporation | 4.62 Billion USD | -1651.449% |
| Thermo Fisher Scientific Inc. | 98.72 Billion USD | 17.917% |
| Biogen Inc. | 26.84 Billion USD | -201.872% |
| Nektar Therapeutics | 398.03 Million USD | -20259.367% |
| Perrigo Company plc | 10.8 Billion USD | -649.711% |
| Dynavax Technologies Corporation | 997.09 Million USD | -8027.302% |
| Illumina, Inc. | 10.11 Billion USD | -701.474% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -286529.434% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -10284.686% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -36320.141% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -123262.764% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -1084.474% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -48918.268% |
| Evolus, Inc. | 188.99 Million USD | -42777.173% |
| Adicet Bio, Inc. | 207.29 Million USD | -38992.598% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -40951.139% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | -144.971% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -39277.345% |
| FibroGen, Inc. | 423.52 Million USD | -19033.755% |
| Agilent Technologies, Inc. | 10.76 Billion USD | -652.922% |
| OPKO Health, Inc. | 2.01 Billion USD | -3928.289% |
| Homology Medicines, Inc. | 47.05 Million USD | -172110.298% |
| Geron Corporation | 394.07 Million USD | -20463.8% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -2015.915% |
| Exelixis, Inc. | 2.94 Billion USD | -2654.153% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -21891.642% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -52389.863% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -6128.934% |
| Zoetis Inc. | 14.28 Billion USD | -467.248% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -13676.273% |
| Abeona Therapeutics Inc. | 64 Million USD | -126516.358% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | -256.517% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -144740.837% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -2610.202% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -2382.313% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -12938.581% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -4575.382% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -7623.326% |
| Insmed Incorporated | 1.32 Billion USD | -5993.754% |
| TG Therapeutics, Inc. | 329.58 Million USD | -24487.438% |
| Incyte Corporation | 6.78 Billion USD | -1094.865% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -4316.426% |